Changing Innovation in the Pharmaceutical Industry: by Andre Jungmittag, Guido Reger, Thomas Reiss

By Andre Jungmittag, Guido Reger, Thomas Reiss

The internationalization of analysis and expertise is one key portion of the globalization of exchange and enterprise, with most likely significant affects on styles of monetary improvement and public guidelines all over the world. even if yes elements of this internationalization pattern are good documented, and a few results could be quantified, the general techniques are tremendous advanced and the results are hugely doubtful. The life of the phenomenon is mostly permitted, yet its value and the tendencies are presently the subject of a full of life debate. This learn on "New methods in Drug improvement in prescribed drugs" is a part of a 3 yr venture which goals at investigating how new suggestions of business wisdom production are carried out within the varied environ­ ments of the innovation structures of the us and Germany. the focus of the final venture is a sequence of case reviews of innovation perform in several nationwide and sectoral contexts. the next sectors and technological fields are investigated: prescription drugs and new methods in drug improvement by means of the Fraunhofer Institute for structures and Innovation study (ISI), complex fabrics via the collage Hohenheim, Insti­ tute of foreign administration and Innovation (Alexander Gerybadze), monetary companies and residential banking via the Massachusetts Institute of Tech­ nology (MIT), middle for commercial functionality (Richard Lester) and the Sloan college of administration (Edward Roberts). Financially the undertaking used to be supported by way of the German-American educational Council, the German Federal Minstry of schooling, technological know-how examine and know-how and the Fraunhofer Society.

Show description

By Andre Jungmittag, Guido Reger, Thomas Reiss

The internationalization of analysis and expertise is one key portion of the globalization of exchange and enterprise, with most likely significant affects on styles of monetary improvement and public guidelines all over the world. even if yes elements of this internationalization pattern are good documented, and a few results could be quantified, the general techniques are tremendous advanced and the results are hugely doubtful. The life of the phenomenon is mostly permitted, yet its value and the tendencies are presently the subject of a full of life debate. This learn on "New methods in Drug improvement in prescribed drugs" is a part of a 3 yr venture which goals at investigating how new suggestions of business wisdom production are carried out within the varied environ­ ments of the innovation structures of the us and Germany. the focus of the final venture is a sequence of case reviews of innovation perform in several nationwide and sectoral contexts. the next sectors and technological fields are investigated: prescription drugs and new methods in drug improvement by means of the Fraunhofer Institute for structures and Innovation study (ISI), complex fabrics via the collage Hohenheim, Insti­ tute of foreign administration and Innovation (Alexander Gerybadze), monetary companies and residential banking via the Massachusetts Institute of Tech­ nology (MIT), middle for commercial functionality (Richard Lester) and the Sloan college of administration (Edward Roberts). Financially the undertaking used to be supported by way of the German-American educational Council, the German Federal Minstry of schooling, technological know-how examine and know-how and the Fraunhofer Society.

Show description

Read Online or Download Changing Innovation in the Pharmaceutical Industry: Globalization and New Ways of Drug Development PDF

Similar international books

After 2015: International Development Policy at a Crossroads (Rethinking International Development)

This publication discusses the Millenium improvement targets (MDGs) - the UN Poverty goals for 2015. half one discusses the heritage to the MDGs, their worth and omissions, what they suggest for altering understandings of 'development' and improvement stories and no matter if the MDGs might be accomplished. half makes a speciality of every one aim or set of targets: severe poverty (income and hunger); schooling and health and wellbeing; gender equality and empowerment; environmental sustainability and international partnerships for improvement.

Machine Learning of Robot Assembly Plans

The research of synthetic intelligence (AI) is certainly an odd pursuit. in contrast to so much different disciplines, few AI researchers even agree on a together appropriate definition in their selected box of research. a few see AI as a sub box of desktop technological know-how, others see AI as a computationally orientated department of psychology or linguistics, whereas nonetheless others see it as a bag of tips to be utilized to a whole spectrum of numerous domain names.

Neural Information Processing: 13th International Conference, ICONIP 2006, Hong Kong, China, October 3-6, 2006. Proceedings, Part II

The 3 quantity set LNCS 4232, LNCS 4233, and LNCS 4234 constitutes the refereed court cases of the thirteenth foreign convention on Neural info Processing, ICONIP 2006, held in Hong Kong, China in October 2006. The 386 revised complete papers offered have been conscientiously reviewed and chosen from 1175 submissions.

Additional resources for Changing Innovation in the Pharmaceutical Industry: Globalization and New Ways of Drug Development

Example text

In the case of Germany, however, it must be said that national regulations in this area are being increasingly replaced by regulations applicable for the whole of the European Union. The significant catalyst for this development was, besides the general European integration process, also the rapid technological development in the field of biotechnology, which again had repercussions on the entire pharmaceutical industry. According to the interdisciplinarity of the pharmaceutical industry, the policies for R&D, patenting and regulation are strongly connected with the present stage of development in the new field biotechnology which raises issues where there is a great deal of uncertainty.

2 Systems of Innovation in the German and US Pharmaceutical Sector 25 real question here. Firstly, as shown above, the public share of funding the healthcare system is much smaller in the US anyway and secondly, the patients' own contributions for medical services are very much higher. For example, with Medicare (the health insurance for the over 65s) , the own contribution for medicine amounts to 100 %. Patients' own contribution towards medicine is much lower in Germany. The patients' contribution for medicine not on the fixed amount list are charged according to the package size and "fixed amount medicines" are reimbursed up to the limit of the fixed amount.

However, Germany, France and Great Britain are still large producers of pharmaceuticals. 17. There is a clear separation between small export countries with above average annual growth rates and large export countries with below average annual growth rates. Japan belongs also to the first group with fast growing exports. High growth rates of the smaller export countries indicate that they are catching up. However, due to different country sizes, this can be only a relative catching up. The group of the large export countries remains stable over time.

Download PDF sample

Rated 4.05 of 5 – based on 7 votes